ARTICLE | Clinical News
NGX-4010 regulatory update
September 29, 2008 7:00 AM UTC
NeurogesX Inc. (NASDAQ:NGSX), San Carlos, Calif. Product: NGX-4010 Business: Neurology NeurogesX submitted a response to EMEA's Day 120 questions on an MAA for NGX-4010 to treat peripheral neuropathi...